Clinical Trials Browser

Approved for marketing × Non-Muscle Invasive Bladder Neoplasms × 90 days × Clear all

NCT06877676 2026-02-13

Pre-Approval Expanded Access Study for TAR-200 Treating Physician Use

Approved for marketing

Non-Muscle Invasive Bladder Neoplasms